Evalve

Evalve

Designing the future of cardiac valve repair through innovative non-surgical solutions.

Founded 1999 Series D Total: $110.90M Health Care, Manufacturing +1

Evalve is a healthcare startup founded in 1999 that focuses on the design, development, manufacture, and marketing of innovative non-surgical solutions for cardiac valve repair. The company's non-surgical solution for mitral valve repair comprises a steerable guide catheter, a clip delivery system, and an implant device, all of which are utilized by interventional cardiologists to mitigate mitral regurgitation. Evalve is headquartered in Menlo Park, California. The company secured a noteworthy $60.00M Series D investment on 27 November 2007, with key investors including New Enterprise Associates, ABS Ventures, Delphi Ventures, Integral Capital Partners, Split Rock Partners, Cutlass Capital, Sterling Capital Management, and Abbott. Evalve's commitment to revolutionizing cardiac valve repair through cutting-edge non-surgical solutions positions it favorably in the Healthcare and Manufacturing industries. The company's ability to attract significant investments from reputable venture capital firms underscores the confidence of industry leaders in its vision and potential. With a strong foundation, innovative product offerings, and substantial financial backing, Evalve is well-positioned for continued growth and success in the healthcare technology sector.

Funding Stage	Amount	Investors	Lead Investors	Date
Series D	$60.00M	8	New Enterprise Associates, ABS Ventures +6	27 Nov 2007
Series C	$35.00M	2	New Enterprise Associates, Delphi Ventures	25 May 2004
Series B	$15.90M	-		01 Jan 2001

Funding Stage

Amount

Investors

Lead Investors

Date

Series D

$60.00M

New Enterprise Associates, ABS Ventures +6

27 Nov 2007

Series C

$35.00M

New Enterprise Associates, Delphi Ventures

25 May 2004

Series B

$15.90M

01 Jan 2001

FAQ About Evalve

Designing the future of cardiac valve repair through innovative non-surgical solutions.

Evalve was founded in 1999.

Evalve operates in Health Care, Manufacturing and Medical Devices. Its work centres on cardiac valve repair, non-surgical solution, mitral valve repair and interventional cardiology.

Evalve has completed 3 funding rounds, raising a total of $110.90M. The latest funding stage is Series D.

Top alternatives and competitors to Evalve include Mitralign Inc., Hanyu Medical, Cardiac Dimensions, Protembis GmbH, Moray Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Evalve and Mitralign Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Evalve

Funding Rounds & Investors (3)

Evalve Alternatives & Competitors

FAQ About Evalve